Are personalized tongxie formula based on diagnostic analyses more effective in reducing IBS symptoms?-A randomized controlled trial.

CONCLUSION: The outcomes in subpopulations may be different from those of the entire population, indicating that personalized formulas are important to achieve optimal outcomes; the active ingredients and innovative mechanisms identified in this study can be the candidates for developing new IBS drugs, and used to manage IBS, respectively.
TRIAL REGISTRATION: NCT01641224 (www.ClinicalTrials.gov).
PMID: 30219477 [PubMed - in process]

Source: Complementary Therapies in Medicine - September 18, 2018 Category: Complementary Medicine Authors: Wang Y, Fan H, Qi X, Lai Y, Yan Z, Li B, Tang M, Huang D, Li Z, Chen H, Zhu Q, Luo C, Chen X, Fen J, Jiang Z, Zheng L, Liu X, Tang Q, Zuo D, Ye J, Yang Y, Huang H, Tang Z, Lu W, Xiao J, Pharm D for the China Irritable Bowel Syndrome Consortium Tags: Complement Ther Med Source Type: research